"Designing Growth Strategies is in our DNA"
Patient-specific implants are personalized medical devices tailored for individual patients, offering enhanced precision and improved surgery outcomes. These implants are used to improve and facilitate precise implantation, with the overall aim to improve the outcome of key surgical procedures, such as arthroplasty. These custom-made and standard implants are mainly used in ankle arthroplasty, osteotomies, shoulder arthroplasty, and knee arthroplasty. Patient-specific implant (PSI) technology aims to reduce overall procedural costs, maximize patient outcomes, and minimize surgical time by achieving better biomechanical implant fits.
Furthermore, the constant technological advancements, such as the use of imaging technologies such as computed tomography and magnetic resonance imaging (MRI) in patient-specific implants, are also driving the market growth. The rise of smart technologies has extended its reach toward dental implants, cranial implants, and others with innovative solutions aimed at improving post-implant monitoring. Innovations include smart implants that are fixed with sensors that provide real-time data on factors such as temperature and pressure.
In addition, the growing investments in research and development activities by the companies have further contributed to the market growth. Companies are continuously working toward innovation and the advancements of implant technologies.
The COVID-19 pandemic negatively impacted the market due to disruptions in the global supply chains, which affected the availability of raw materials and components necessary for implant manufacturing. This led to temporary shortages and delays in product launches. Moreover, the pandemic led to a substantial disruption in elective surgeries, including patient-specific implants. Hospitals and healthcare facilities prioritized COVID-19 treatment, postponing non-urgent procedures to allocate resources and reduce the risk of transmission.
|
By Product |
By Material |
By Application |
By End User |
By Geography |
|
|
|
|
|
The report covers the following key insights:
By product, the market is segmented into cranial implants, orthopedic implants, dental implants, and others. The orthopedic implants segment accounted for a significant market share in 2023. The growth was mainly due to the increasing prevalence of orthopedic conditions such as osteoarthritis, rheumatoid arthritis, and traumatic injuries, which is increasing the need for surgical interventions. These patient-specific orthopedic implants are increasingly providing durable and effective solutions for joint replacements, spinal surgeries, and others, boosting their demand.
Moreover, significant advancements in 3D printing and computer-aided design technologies have revolutionized the development of orthopedic implants, further augmenting segmental growth.
Furthermore, the cranial implants segment is projected to witness fast growth in the forecast period owing to the growing awareness among patients and healthcare providers regarding the benefits of advanced neurosurgical procedures that utilize patient-specific implants.
Moreover, these implants have shown significant potential in exhibiting enhanced recovery rates, owing to an increasing number of neurosurgeons adopting these technologies. Thus, the aforementioned factors will further contribute to the growing demand for cranial implants in the coming years.
To gain extensive insights into the market, Download for Customization
The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to account for a significant share of the global patient-specific implants market. Advanced healthcare infrastructure and the presence of skilled healthcare providers enable the rapid integration of patient-specific implants into clinical practices, ensuring that patients have access to the latest available treatment options. Thus, constant technological advancements coupled with the growing focus on better treatment options are surging the adoption of these products in the region.
Asia Pacific is projected to witness the fastest growth rate in the coming years owing to the growing healthcare expenditure in the region coupled with an increasing focus on research and innovation toward the development of new implants by academic and research institutes. These new implants will assist healthcare providers in implementing and designing custom implants for patients to provide better treatment options. Thus, increasing research and development activities in countries such as China, India, and others contribute to market growth.
The report includes the profiles of key players, such as Zimmer Biomet, Onkos, Materialise, Stryker, Johnson & Johnson Services, Inc., and 3D Systems, Inc.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )